| Products | Glycosal HbA1c Tester |
| Company | Provalis |
| Item | Glycosal HbA1c Tester |
| Features | - CLIA waiver.
- Prescription home use status in the US.
- Standardised to the Diabetes Control and Complications Trial (DCCT).
- Certified by the European Reference Laboratory, to ensure traceability of results to the DCCT.
- Compared to the major laboratory methods of HbA1c testing and achieved correlation in excess of r = 0.97 with all of them.
- Normal and abnormal HbA1c controls are available to allow users of the test to carry out their own Quality Control.
- The HaemaQuant instrument incorporates software to eliminate user error.
- Manufactured to the highest ISO9001 requirements.
- Participates in external quality assessment schemes to ensure on-going performance.
- Certified by the National Glycohaemoglobin Standardisation Programme (NGSP) in the USA.
|
| Description | Long term complications associated with diabetes continue to have a tremendous impact on the health and quality of life of patients, in addition to the significant economic costs. These complications are known to be associated with elevated levels of blood glucose. The discovery that the level of haemoglobin A1c (HbA1c) in a diabetic patient's blood, reflects the average blood glucose concentration over the previous 90-120 day period, was a significant aid to treatment of the disease. |
| Info | Provalis Customer Service: +44 (0) 1244 288 888 Web site: http://www.provalis.com/HTMLFiles/start.html |
.
.
.
.
.
.
.
.
.
.
.